Sun Pharma Advanced Research Company Ltd
NSE: SPARC BSE: 532872
₹114.89
(-4.96%)
Wed, 01 Apr 2026, 10:42 am
Market Cap37.19B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSun Pharma Advanced Research Company Analysis
dividend
- Unable to evaluate Sun Pharma Advanced Research's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Sun Pharma Advanced Research's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Sun Pharma Advanced Research's cash and other short term assets cover its long term commitments.
- Sun Pharma Advanced Research's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Sun Pharma Advanced Research has less than a year of cash runway if free cash flow continues to grow at historical rates of 32.1% each year.
- Sun Pharma Advanced Research has less than a year of cash runway based on current free cash flow.
- Operating cash flow is negative therefore debt is not well covered.
- Sun Pharma Advanced Research has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
- Irrelevant to check if Sun Pharma Advanced Research's debt level has increased considering it has negative shareholder equity.
- Sun Pharma Advanced Research has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.
- High level of physical assets or inventory.
management
- The average tenure for the Sun Pharma Advanced Research board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- The average tenure for the Sun Pharma Advanced Research management team is over 5 years, this suggests they are a seasoned and experienced team.
misc
- Sun Pharma Advanced Research is not covered by any analysts.
- Sun Pharma Advanced Research has significant price volatility in the past 3 months.
past
- Unable to compare Sun Pharma Advanced Research's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Sun Pharma Advanced Research does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Sun Pharma Advanced Research has efficiently used its assets last year compared to the IN Pharmaceuticals industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Sun Pharma Advanced Research improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Sun Pharma Advanced Research has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.
- Unable to compare Sun Pharma Advanced Research's 1-year growth to the IN Pharmaceuticals industry average as it is not currently profitable.
value
- SPARC outperformed the Market in India which returned -14.5% over the past year.
- NSEI:SPARC is up 11.1% outperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- NSEI:SPARC is up 11.1% outperforming the market in India which returned 8% over the past month.
- Sun Pharma Advanced Research has negative assets, we can't compare the value of its assets to the IN Pharmaceuticals industry average.
- Sun Pharma Advanced Research is loss making, we can't compare its value to the IN Pharmaceuticals industry average.
- Sun Pharma Advanced Research is loss making, we can't compare the value of its earnings to the India market.
- SPARC underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800